Monosodium Phosphate E339 (i) is the sodium salt of phosphoric acid. It appears as a white powder, and is an acidulant, buffer, and sequestrant. It is often used in soft drinks, cheese, etc. Though Monosodium Phosphate E339 (i) is considered safe, some are convinced it has potentially dangerous health effects.
What Is Monosodium Phosphate E339 (i)?
Monosodium Phosphate E339 (i) is a white loose, non-aggressive and non-flammable substance. It is often used as a buffer, sequestrant, and stabilizer in dairy products, meats, and seafood. It can also be used as a pH adjuster in beverages and a treatment agent in drinking water.
Possible Side Effects of Monosodium Phosphate E339 (i)
Though Monosodium Phosphate E339 (i) is regarded as safe supplement, there maybe some side effects:
- Abdominal or stomach pain
GRAS Affirmation: Yes
Generally recognized as safe (GRAS) is an American Food and Drug Administration (FDA) designation that a chemical or substance added to food is considered safe by experts, and so is exempted from the usual Federal Food, Drug, and Cosmetic Act (FFDCA) food additive tolerance requirements. Monosodium Phosphate E339 (i) is considered safe.
Special Populations Precaution
There is a lot of concern about diet and nutrition for these population, like Newborns, children, pregnant, sensitive to Monosodium Phosphate E339 (i) populations. Better consult to your doctor if you would like to intake Monosodium Phosphate.
Monosodium Phosphate in News
No breaking news or public health crises reported about Monosodium Phosphate E339 (i) reported up to now.
1. Synthesis and preclinical evaluations of 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one monosodium phosphate (CHM-1-P-Na) as a potent antitumor agent. [J Med Chem. 2010 Feb 25] Author: Chou LC, Chen CT, Lee JC, Way TD, Huang CH, Huang SM, Teng CM, Yamori T, Wu TS, Sun CM, Chien DS, Qian K, Morris-Natschke SL, Lee KH, Huang LJ, Kuo SC.
2. [Changes in the content of adrenaline and noradrenaline in the brain, heart and adrenal glands of rats, following the administration of monosodium phosphate, hydrocortisone and desoxycorticosterone]. [Acta Physiol Pol. 1968 Nov-Dec] Author: Górny D.